From Genomics
to Precision Medicine

Realizing The Potential
of the Spliceosome

We Are H3

December 15, 2017
Read More »
December 9, 2017
Read More »
December 6, 2017
Read More »
October 24, 2017
Read More »
September 15, 2017
Read More »
September 5, 2017
Read More »
August 14, 2017
Read More »
July 24, 2017
Read More »
Read More »
June 1, 2017
Read More »
May 25, 2017
Read More »
May 1, 2017
Read More »

H3 Science

Our Approach

H3 Biomedicine takes a target-centric approach to drug discovery through use of biological proof-of-concept milestones to enable project…

Learn More »

Cancer Genomics

Acquired changes of the genome of cancer cells are key in disrupting the physiological function of normal cells of the body and their transformation…

Learn More »

Pipeline

Through its deep understanding of cancer genomics and target-centric drug discovery approach, H3 has assembled a compelling…

Learn More »

I am H3

“H3 scientists are focused on answering key research questions and validating underlying scientific fundamentals; all in the interest of developing breakthrough medicines to treat cancer. H3 is comprised of a group of passionate scientists who understand that our work may have a profound impact on patients’ lives. We strive to understand the potential for these medicines and how they may benefit cancer patients.”
Morgan Welzel O’Shea, Discovery Chemistry

Learn More